Ayr Wellness Inc. (OTCMKTS:AYRWF - Get Free Report) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 1,012,900 shares, a drop of 13.8% from the December 31st total of 1,174,700 shares. Based on an average daily volume of 773,100 shares, the short-interest ratio is presently 1.3 days.
Ayr Wellness Trading Down 9.3 %
OTCMKTS AYRWF traded down $0.04 on Tuesday, hitting $0.44. 182,932 shares of the stock were exchanged, compared to its average volume of 127,628. The company's 50-day moving average price is $0.48 and its two-hundred day moving average price is $1.32. The company has a market capitalization of $50.60 million, a price-to-earnings ratio of -0.20 and a beta of 1.64. Ayr Wellness has a 52-week low of $0.36 and a 52-week high of $3.46. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.59 and a quick ratio of 0.58.
Wall Street Analysts Forecast Growth
AYRWF has been the subject of a number of research reports. Roth Mkm decreased their target price on Ayr Wellness from $3.50 to $3.00 and set a "buy" rating for the company in a research note on Thursday, November 14th. Roth Capital upgraded Ayr Wellness to a "strong-buy" rating in a research report on Friday, November 8th. Finally, Atb Cap Markets lowered Ayr Wellness from a "hold" rating to a "strong sell" rating in a research report on Wednesday, November 13th.
Check Out Our Latest Report on Ayr Wellness
About Ayr Wellness
(
Get Free Report)
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
Featured Articles
Before you consider Ayr Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ayr Wellness wasn't on the list.
While Ayr Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.